Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PKPOP Study of Didanosine in HIV Treated Children
NCT00668356Phase 2Suspended
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of didanosine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Pharmacokinetic parameters at 56 days. Started Sep 2009; status: suspended.
02
Drugs
didanosine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00668356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00668356.